λ2-cobalt(2+) ion (2R,3S,4S,6Z,8S,9S,11Z,14S,16Z,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2S)-2-{[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.12,5.17,10.112,15]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-ide hydrate

• ChemBase编号: 130508
• 分子式: C62H90CoN13O15P
• 平均质量: 1347.363061
• 单一同位素质量: 1346.57489088
• SMILES: Cc1cc2c(cc1C)n(cn2)[C@@H]1[C@@H]([C@@H]([C@H](O1)CO)OP(=O)([O-])O[C@@H](C)CNC(=O)CC[C@@]1([C@H](C2[C@]3([C@@]([C@@H](C(=N3)/C(=C\3/[C@@]([C@@H](C(=N3)/C=C\3/C([C@@H](C(=N3)/C(=C/1\[N-]2)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]
• Canonical SMILES: OC[C@H]1O[C@@H]([C@@H]([C@@H]1OP(=O)(O[C@H](CNC(=O)CC[C@@]1(C)/C/2=C(\C)/C3=N/C(=C\C4=N/C(=C(\C5=N[C@](C([C@@H]1CC(=O)N)[N-]2)(C)[C@@](C)(CC(=O)N)[C@@H]5CCC(=O)N)/C)/[C@@]([C@@H]4CCC(=O)N)(C)CC(=O)N)/C([C@@H]3CCC(=O)N)(C)C)C)[O-])O)n1cnc2c1cc(C)c(c2)C.O.[Co+2]
• InChI: InChI=1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+2;/p-2/t31-,34+,35+,36+,37-,41+,52+,53+,56?,57-,59+,60-,61-,62-;;/m0../s1
• InChIKey: DQOCFCZRZOAIBN-PMEYKKDOSA-L

名称和登记号

名称

• IUPAC标准名: λ^2-cobalt(2+) ion (2R,3S,4S,6Z,8S,9S,11Z,14S,16Z,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2S)-2-{[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1^2,^5.1^7,^1^0.1^1^2,^1^5]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-ide hydrate
• IUPAC传统名: λ^2-cobalt(2+) ion (2R,3S,4S,6Z,8S,9S,11Z,14S,16Z,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2S)-2-{[(2R,3S,4R,5S)-5-(5,6-dimethyl-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1^2,^5.1^7,^1^0.1^1^2,^1^5]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-ide hydrate
• 别名: Hydroxocobalamin

登记号

• CAS号: 13422-51-0
• PubChem SID: 162224787
• PubChem CID: 6433575; 50935334
• ATC码: B03BA03; V03AB33
• CHEMBL: 1237097
• Chemspider ID: 21160115
• DrugBank ID: DB00200
• KEGG ID: D01027
• 美国药典/FDA物质标识码: Q40X8H422O
• 维基百科标题: Hydroxocobalamin
• Medline Plus: a605007

理论计算性质

• Acid pKa: 1.8412305
• 质子受体: 17
• 质子供体: 9
• LogD (pH = 5.5): -7.2647085
• LogD (pH = 7.4): -3.3802807
• Log P: -2.7134063
• 摩尔折射率: 330.719 cm^3
• 极化性: 129.30844 Å^3
• 极化表面积: 460.05 Å^2
• 可自由旋转的化学键: 26
• 里宾斯基五规则: false

分子性质

药理学性质

• 给药途径: Injectable (intramuscular, intravenous, or subcutaneous)
• 半衰期: ~6 days
• 代谢: Primarily hepatic, cobalamins are absorbed in the ileum and stored in the liver.
• 蛋白结合率: Very high (90%)
• 法定药品分级: Prescription injectable in U.S. Not DEA-controlled